Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
562
Views
6
CrossRef citations to date
0
Altmetric
Author's View

The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products

Philip J. Vernon Department of Surgery; Hillman Cancer Center; University of Pittsburgh Cancer Institute; Pittsburgh, PA USA
,
Herbert J. Zeh III Department of Surgery; Hillman Cancer Center; University of Pittsburgh Cancer Institute; Pittsburgh, PA USA
&
Michael T. Lotze Department of Surgery; Hillman Cancer Center; University of Pittsburgh Cancer Institute; Pittsburgh, PA USACorrespondence[email protected]
Article: e24184 | Received 27 Feb 2013, Accepted 03 Mar 2013, Published online: 01 May 2013

References

  • Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67:9518 - 27; http://dx.doi.org/10.1158/0008-5472.CAN-07-0175; PMID: 17909062
  • Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 2011; 9:133 - 48; http://dx.doi.org/10.1158/1541-7786.MCR-10-0394; PMID: 21228116
  • Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007; 220:60 - 81; http://dx.doi.org/10.1111/j.1600-065X.2007.00579.x; PMID: 17979840
  • Kang R, Loux T, Tang D, Schapiro NE, Vernon P, Livesey KM, et al. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proceedings of the National Academy of Sciences 2012; http://dx.doi.org/10.1073/pnas.1113865109
  • Muthuswamy R, Berk E, Junecko BF, Zeh HJ, Zureikat AH, Normolle D, et al. NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells. Cancer Res 2012; 72:3735 - 43; http://dx.doi.org/10.1158/0008-5472.CAN-11-4136; PMID: 22593190
  • Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010; 17:666 - 76; http://dx.doi.org/10.1038/cdd.2009.149; PMID: 19834494
  • Wang L, Chang EWY, Wong SC, Ong S-M, Chong DQY, Ling KL. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 2013; 190:794 - 804; http://dx.doi.org/10.4049/jimmunol.1202088; PMID: 23248262
  • Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4:437 - 50; http://dx.doi.org/10.1016/S1535-6108(03)00309-X; PMID: 14706336
  • Vernon PJ, Loux TJ, Schapiro NE, Kang R, Muthuswamy R, Kalinski P, et al. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. J Immunol 2013; 190:1372 - 9; http://dx.doi.org/10.4049/jimmunol.1201151; PMID: 23269246
  • Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331:1612 - 6; http://dx.doi.org/10.1126/science.1198443; PMID: 21436454

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.